Pancreatic Cancer Serum and Peripheral Blood Lymphocyte Repository
- Establish a central pancreatic cancer specimen (including serum and peripheral blood
lymphocytes) repository to serve as a resource for current or future scientific
- Utilize the clinical database to perform clinicopathologic correlation with the results
of those studies.
- Test new hypotheses as they emerge.
OUTLINE: This is a prospective study.
Blood is collected from patients with pancreatic cancer at baseline and then every 3-6
months for up to 2 years. All other participants have blood collected at baseline and
complete questionnaires at baseline and then every 3-6 months for up to 2 years. Serum and
peripheral blood lymphocytes obtained from the blood samples are frozen and stored.
PROJECTED ACCRUAL: A total of 200 patients and 200 other participants will be accrued for
Observational Model: Case-Only
Establishment of a central pancreatic cancer specimen repository
No time frame
Daniel A. Laheru, MD
Sidney Kimmel Comprehensive Cancer Center
United States: Federal Government